Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Boston Scientific Corp (BSX)

Boston Scientific Corp (BSX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 103,348,608
  • Shares Outstanding, K 1,486,175
  • Annual Sales, $ 20,074 M
  • Annual Income, $ 2,898 M
  • EBIT $ 4,509 M
  • EBITDA $ 5,923 M
  • 60-Month Beta 0.69
  • Price/Sales 5.14
  • Price/Cash Flow 17.32
  • Price/Book 4.24

Options Overview Details

View History
  • Implied Volatility 45.73% (-1.40%)
  • Historical Volatility 25.10%
  • IV Percentile 97%
  • IV Rank 80.31%
  • IV High 52.68% on 04/04/25
  • IV Low 17.38% on 07/29/25
  • Expected Move (DTE 3) 2.04 (2.93%)
  • Put/Call Vol Ratio 0.19
  • Today's Volume 18,249
  • Volume Avg (30-Day) 24,209
  • Put/Call OI Ratio 0.41
  • Today's Open Interest 358,585
  • Open Int (30-Day) 402,979
  • Expected Range 67.50 to 71.58

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 31 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate 0.80
  • Number of Estimates 9
  • High Estimate 0.86
  • Low Estimate 0.78
  • Prior Year 0.75
  • Growth Rate Est. (year over year) +6.67%

Price Performance

See More
Period Period Low Period High Performance
1-Month
67.56 +2.93%
on 03/12/26
76.87 -9.54%
on 02/27/26
-4.83 (-6.49%)
since 02/23/26
3-Month
67.56 +2.93%
on 03/12/26
100.90 -31.08%
on 01/08/26
-26.55 (-27.63%)
since 12/23/25
52-Week
67.56 +2.93%
on 03/12/26
109.50 -36.49%
on 09/09/25
-31.15 (-30.94%)
since 03/21/25

Most Recent Stories

More News
Robbins LLP Urges BSX Stockholders Who Lost Money Investing in Boston Scientific Corporation to Contact the Firm for Information About Leading the Class Action

SAN DIEGO , March 23, 2026 /PRNewswire/ -- Robbins LLP  reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Boston Scientific Corporation...

BSX : 69.54 (+0.09%)
Boston Scientific Corporation (BSX) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

BENSALEM, Pa. , March 20, 2026 /PRNewswire/ -- The Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action...

BSX : 69.54 (+0.09%)
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Boston Scientific Corporation of Class Action Lawsuit and Upcoming Deadlines - BSX

NEW YORK , March 19, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Boston Scientific Corporation ("Boston Scientific" or the "Company") (NYSE: BSX). Such...

BSX : 69.54 (+0.09%)
BSX Investor Alert: BOSTON SCIENTIFIC CORPORATION Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Claims Executives Misrepresented U.S. Electrophysiology Volumes: SueWallSt

Alert: Claims Focus on Alleged Misrepresentations About U.S. Electrophysiology Procedure Growth

BSX : 69.54 (+0.09%)
The Highest-Rated Healthcare Stock to Buy Now to Hedge Against Oil Price Shocks

Amid oil-driven volatility, investors lean on resilient sectors, with Boston Scientific Corporation now standing out as a steady defensive healthcare play.

BSX : 69.54 (+0.09%)
BSX Investor Alert: BOSTON SCIENTIFIC CORPORATION Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Claims Executives Misrepresented U.S. Electrophysiology Volumes: Levi & Korsinsky

Alert: Claims Focus on Alleged Misrepresentations About U.S. Electrophysiology Procedure Growth

BSX : 69.54 (+0.09%)
BSX Investor Alert: BOSTON SCIENTIFIC CORPORATION Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Claims Executives Misrepresented U.S. Electrophysiology Volumes: Levi & Korsinsky

Alert: Claims Focus on Alleged Misrepresentations About U.S. Electrophysiology Procedure Growth

BSX : 69.54 (+0.09%)
Boston Scientific Corporation (BSX) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

LOS ANGELES , March 17, 2026 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Boston Scientific Corporation ("Boston Scientific" or the "Company")...

BSX : 69.54 (+0.09%)
BSX Shareholder Alert: May 4, 2026 Lead Plaintiff Deadline in Boston Scientific Corporation Securities Class Action Lawsuit -- The Gross Law Firm

NEW YORK , March 17, 2026 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of  Boston Scientific Corporation (NYSE: BSX).

BSX : 69.54 (+0.09%)
BSX Investors Have Opportunity to Lead Boston Scientific Corporation Securities Fraud Lawsuit

NEW YORK , March 16, 2026 /PRNewswire/ --

BSX : 69.54 (+0.09%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Boston Scientific Corporation manufactures medical devices and products used in various interventional medical specialties worldwide. The company has adopted the organic as well as inorganic routes for success. Boston Scientific currently has 3 global reportable segments - Cardiovascular, Rhythm and...

See More

Key Turning Points

3rd Resistance Point 72.13
2nd Resistance Point 71.33
1st Resistance Point 70.44
Last Price 69.54
1st Support Level 68.75
2nd Support Level 67.95
3rd Support Level 67.06

See More

52-Week High 109.50
Fibonacci 61.8% 93.48
Fibonacci 50% 88.53
Fibonacci 38.2% 83.58
Last Price 69.54
52-Week Low 67.56

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.